134 related articles for article (PubMed ID: 23784261)
1. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys.
Mundiñano IC; Hernandez M; Dicaudo C; Ordoñez C; Marcilla I; Tuñon MT; Luquin MR
Acta Neuropathol; 2013 Sep; 126(3):411-25. PubMed ID: 23784261
[TBL] [Abstract][Full Text] [Related]
2. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
[TBL] [Abstract][Full Text] [Related]
3. Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson's disease.
Yang J; Lv DJ; Li LX; Wang YL; Qi D; Chen J; Mao CJ; Wang F; Liu Y; Hu LF; Liu CF
Neurotoxicology; 2019 Jul; 73():175-182. PubMed ID: 30978411
[TBL] [Abstract][Full Text] [Related]
4. Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice.
Szegő ÉM; Outeiro TF; Kermer P; Schulz JB
Neurobiol Aging; 2013 Feb; 34(2):589-601. PubMed ID: 22579457
[TBL] [Abstract][Full Text] [Related]
5. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for cholinergic regulation of neural circuits in the mouse olfactory bulb.
Hamamoto M; Kiyokage E; Sohn J; Hioki H; Harada T; Toida K
J Comp Neurol; 2017 Feb; 525(3):574-591. PubMed ID: 27491021
[TBL] [Abstract][Full Text] [Related]
7. Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease.
Prediger RD; Rial D; Medeiros R; Figueiredo CP; Doty RL; Takahashi RN
Ann N Y Acad Sci; 2009 Jul; 1170():629-36. PubMed ID: 19686204
[TBL] [Abstract][Full Text] [Related]
8. Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice.
Yamada M; Onodera M; Mizuno Y; Mochizuki H
Neuroscience; 2004; 124(1):173-81. PubMed ID: 14960349
[TBL] [Abstract][Full Text] [Related]
9. The isolation of neural stem cells from the olfactory bulb of Parkinson's disease model.
Hayakawa H; Hayashita-Kinoh H; Nihira T; Seki T; Mizuno Y; Mochizuki H
Neurosci Res; 2007 Mar; 57(3):393-8. PubMed ID: 17222932
[TBL] [Abstract][Full Text] [Related]
10. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP.
Belzunegui S; San Sebastián W; Garrido-Gil P; Izal-Azcárate A; Vázquez-Claverie M; López B; Marcilla I; Lanciego JL; Luquin MR
Synapse; 2007 Dec; 61(12):1006-12. PubMed ID: 17853434
[TBL] [Abstract][Full Text] [Related]
11. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
[TBL] [Abstract][Full Text] [Related]
12. Modeling neurodegenerative diseases in vivo review.
von Bohlen Und Halbach O
Neurodegener Dis; 2005; 2(6):313-20. PubMed ID: 16909014
[TBL] [Abstract][Full Text] [Related]
13. Animal models of degenerative neurological disease.
Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
[TBL] [Abstract][Full Text] [Related]
14. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
Carmona-Abellan M; Martinez-Valbuena I; Marcilla I; DiCaudo C; Gil I; Nuñez J; Luquin MR
Neurol Sci; 2021 Apr; 42(4):1473-1482. PubMed ID: 32816165
[TBL] [Abstract][Full Text] [Related]
15. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
[TBL] [Abstract][Full Text] [Related]
16. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces norepinephrine concentrations in the olfactory bulbs of male mice.
Dluzen DE
Brain Res; 1992 Jul; 586(1):144-7. PubMed ID: 1511343
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
Mitsumoto Y; Mori A; Ohashi S; Nakai M; Moriizumi T
Neurosci Res; 2005 Jan; 51(1):111-5. PubMed ID: 15596247
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb.
Franco J; Prediger RD; Pandolfo P; Takahashi RN; Farina M; Dafre AL
Life Sci; 2007 Apr; 80(20):1906-14. PubMed ID: 17382353
[TBL] [Abstract][Full Text] [Related]
20. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
